ACTA1 and Hepatic fibrosis: The combination treatment of SKI-II and DMS reduced collagen and α-SMA accumulation and abrogated the prodifferentiating effect of TGF-β in BMSCs from a mouse model of CCl4-induced liver fibrosis (Yang et al., 2012).